Xavant Technology is a knowledge-based company with core competencies in Neuromuscular Stimulation, Neuromodulation and Accelerometry.
Xavant Technology gains its competitive advantage by introducing disruptive technologies to high-growth Niche Markets with high entry barriers and little rivalry.
As a knowledge based company, Xavant’s biggest asset lies in its specialised R&D team consisting of a dedicated team of medical and electronic engineers working closely with medical consultants to find innovative product solutions for the latest medical techniques.
Creating electromagnetic cures that target the biological root cause of diseased states increasing treatment efficacy whilst eliminating side effects.
Our long-term vision is to replace pharmaceutical medicine with electromagnetic cures which will modulate the neurohumoral system with increased precision and efficacy and without side effects.
CEO: Corlius Birkill, MBA, B.Eng(Hons)
Chairman: Roche van Rensburg, M.Eng
Medical Director: Dr. R Raath, MMChB, MMed (Anaes), (Pret.) FIPP (WIP)